Event to be held on December 6, 2023 will focus on preventing basal cell carcinomas associated with Gorlin syndrome with a discussion of the disease burden, SGT-610 and the upcoming Phase 3 trial ...

About Gorlin Syndrome and SGT-610. SGT-610, a hedgehog signaling pathway blocker, has the potential to be the first ever treatment for prevention of BCCs in Gorlin syndrome patients, if approved.

Sneddon-Wilkinson syndrome. Flaccid pustules that coalesce into annular, polycyclic, or serpiginous configurations are typical of subcorneal pustular dermatosis or Sneddon-Wilkinson disease.